Drug profile · INN
lonapegsomatropin
SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)
lonapegsomatropin (SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)) is a growth hormone receptor agonist.
EMA: approved Systemic hormonal preparations (H01) H01AC09
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — lonapegsomatropin
- Class
- Systemic hormonal preparations (H01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
lonapegsomatropin (SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)) is a growth hormone receptor agonist.
Key facts
INN lonapegsomatropin
Brand SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)
Mechanism Growth hormone receptor agonist
Target Growth hormone receptor
Therapeutic class Systemic hormonal preparations (H01)
ATC code H01AC09
Mechanism of action
Growth hormone receptor agonist
Primary target: Growth hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lonapegsomatropin?
lonapegsomatropin (SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)) is a growth hormone receptor agonist.
What is the brand name for lonapegsomatropin?
SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA) is a marketed brand name for lonapegsomatropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.